Codes / ICD10CM / T37.1X5

T37.1X5 Adverse effect of antimycobacterial drugs

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of antimycobacterial drugs

Summary

This condition refers to harmful or unintended reactions resulting from the use of antimycobacterial medications, which are used to treat mycobacterial infections such as tuberculosis. It includes toxic effects, allergic responses, or other adverse outcomes that may arise during treatment, potentially impacting patient safety or treatment efficacy.

Causes

Adverse effects can result from drug toxicity, allergic reactions, or idiosyncratic responses to antimycobacterial agents. These reactions may occur due to individual patient sensitivity, drug interactions, or improper dosing, even when medications are used as prescribed.

Risk Factors

  • Concurrent use of medications that interact with antimycobacterial drugs.
  • Pre-existing renal or hepatic impairment affecting drug metabolism.
  • History of hypersensitivity to similar drug classes.
  • Lack of proper monitoring or dosage adjustments during therapy.

Symptoms

  • Gastrointestinal: Nausea, vomiting, or abdominal discomfort.
  • Dermatological: Rash, itching, or hypersensitivity reactions.
  • Neurological: Dizziness, confusion, or central nervous system effects.
  • Systemic: Organ-specific toxicity (e.g., hepatic or renal) or metabolic disturbances.

Diagnosis

Clinical evaluation focuses on medication history, symptom onset, and lab tests (e.g., drug levels, organ function). Toxicology screening may confirm exposure, while imaging or other studies evaluate organ damage.

Treatment Options

Management includes discontinuing the offending drug, supportive care (e.g., hydration, antiemetics), and specific interventions for severe reactions (e.g., antihistamines for hypersensitivity). In some cases, alternative antimycobacterial agents may be prescribed.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timely intervention. Most mild adverse effects resolve with discontinuation of the drug, but severe reactions may require prolonged monitoring. Follow-up ensures resolution of symptoms and adjustment of therapy if needed.

Complications

Severe adverse effects can lead to organ damage (e.g., hepatic or renal failure), persistent hypersensitivity, or treatment interruptions. Delayed recognition may worsen outcomes.

Lifestyle & Prevention

Patients should adhere to prescribed dosing, avoid self-adjusting medications, and report new symptoms promptly. Healthcare providers should monitor for early signs of adverse effects and adjust therapy as needed.

When to Seek Professional Help

Seek immediate care for severe symptoms (e.g., difficulty breathing, seizures, or organ-specific pain). Contact a provider for persistent or worsening reactions, even if mild.

Tips for Medical Coders

Document the specific antimycobacterial drug involved, the nature of the adverse effect (e.g., allergic, toxic), and any interventions. Ensure the code T37.1X5 is used only when the adverse effect is the primary reason for care, with clear clinical correlation.

Book a walkthrough

T37.1X5 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.